ElastiMed is a wearable medical device company that has developed a smart sock designed to improve circulation in the legs for treatment of venous and lymphatic diseases. The device uses proprietary technology and innovative smart materials to compress and massage the legs when stimulated by an electric pulse. It aims to provide an affordable treatment option to prevent symptoms such as swelling, blood clots, leg ulcers, and sports injuries. The company is led by Founder & CEO Omer Zelka and is based in Misgav, Israel. ElastiMed raised US$1m in its second funding round, bringing total capital raised to US$2m to date. The company intends to use the funds to conduct a clinical study, pursue regulatory filings, and further expand its intellectual property. ElastiMed, based in Tradyon, Israel, develops a wearable medical stocking that uses smart materials to treat Chronic Venous Insufficiency (CVI) and prevent Deep Venous Thrombosis (DVT). The company's core product is a smart-material stocking designed to improve patient compliance compared with traditional compression therapies. Led by CEO Omer Zelka, ElastiMed is a portfolio company of Trendlines Medical, a commercialization and incubation group. In September 2015 ElastiMed raised $1m in venture capital funding. The company intends to use the funds to complete R&D, pursue regulatory filings and commence clinical trials.

Total raised

$2M

Funding rounds

2

Latest round

Equity

Latest activity

Sep 2017